[1]郑政,刘丹宁,周希瑗,等.玻璃体腔注射lucentis治疗白内障术后顽固性黄斑水肿的疗效[J].第三军医大学学报,2016,38(20):2287-2290.
 Zheng Zheng,Liu Danning,Zhou Xiyuan,et al.Effect of intravitreal injection of lucentis for refractory macular edema after cataract surgery[J].J Third Mil Med Univ,2016,38(20):2287-2290.
点击复制

玻璃体腔注射lucentis治疗白内障术后顽固性黄斑水肿的疗效(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
38卷
期数:
2016年第20期
页码:
2287-2290
栏目:
临床医学
出版日期:
2016-10-30

文章信息/Info

Title:
Effect of intravitreal injection of lucentis for refractory macular edema after cataract surgery
作者:
郑政刘丹宁周希瑗胡晓鹏武明星
重庆医科大学附属第二医院眼科
Author(s):
Zheng Zheng Liu Danning Zhou Xiyuan Hu Xiaopeng Wu Mingxing

Department of Ophthalmology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China

关键词:
白内障术后黄斑水肿抗VEGF视功能lucentis
分类号:
R774.5;R776.1;R977
文献标志码:
A
摘要:

目的       通过玻璃体腔单次注射抗血管内皮生长因子(vascular endothelial growth factor,VEGF)药物lucentis观察治疗顽固性黄斑水肿的临床疗效和安全性。 方法     收集2014年7月至2015年7月在我科白内障超声乳化联合人工晶体植入术后发生顽固性黄斑水肿患者9例(10眼),病史均大于3个月。荧光素眼底血管造影(fundus fluoresceinangiography,FFA)及光学相干断层扫描(optical coherence tomography,OCT)检查确诊并排除黄斑相关疾病引起的黄斑水肿。患眼玻璃体腔单次注射lucentis 0.5 mg(0.05 mL),治疗后随访12周,对比观察治疗前后患眼视力、眼压、OCT及FFA改变。  结果        9例患者10只眼治疗后1周视力明显提高,4、12周后视力稳定;与治疗前比较,差异均具有统计学意义(P<0.01)。OCT检查黄斑中心凹视网膜厚度(central foveal thickness, CFT),从治疗前(480±121)μm,下降至治疗后1周(293±58)μm,4、12周厚度分别保持在(231±23)、(235±35)μm,治疗前后比较,差异均具有统计学意义(P<0.01),所有患者均未出现眼内或全身不良反应。 结论         玻璃体腔注射lucentis治疗白内障术后顽固性黄斑水肿能明显改善患者视功能,减轻黄斑水肿,无副作用。

Abstract:

Objective        To observe the clinical efficacy and safety of single intravitreal injection of anti-vascular endothelial growth factor (VEGF) agent, lucentis, for refractory macular edema after cataract surgery.     Methods       Nine patients (10 eyes)with refractory macular edema after cataract surgery (phacoemulsification combined with intraocular lens implantation)at our department from July 2014 to July 2015 were included in the study. All patients had medical history of refractory macular edema longer than 3 months, confirmed by examinations of optical coherence tomography (OCT) and fundus fluorescein angiography (FFA). Macular edema caused by other macular-related disease were excluded, and patients had no any systemic and local operation contraindication. The central foveal thickness(CFT) before treatment were 480±121 μm. For the affected eyes, single intravitreal injection of lucentis 0.5 mg(0.05 mL)was administrated. Follow-up period continued for 12 weeks. The changes of visual acuity (VA), intraocular pressure, OCT and FFA were compared before and after the treatment.   Results       The VA of 9 patients (10 eyes) was obviously improved in 1 week after treatment, with stable vision at the 4 and 12 weeks. The VA differences between the pre- and after lucentis injection were statistically significant(P<0.01). For the CFT measured by OCT,it dropped to 293±58 μm in 1 week after therapy, with the thickness of 231±23 μm and 235±35 μm at the 4 and 12 weeks, respectively. The differences of CFT before and after treatment were also statistically significant. Meanwhile, no patients experienced ocular or systemic adverse reactions.   Conclusion        Intravitreal injection of lucentis for refractory macular edema after cataract surgery can significantly improve the patients’ visual function, and reduce macular edema with no side effect observed.

参考文献/References:

[1]Gharbiya M, Cruciani F, Cuozzo G, et al. Macular thickness changes evaluated with spectral domain optical coherence tomography after uncomplicated phacoemulsification[J]. Eye, 2013, 27(5): 605-611. DOI: 10. 1038/eye. 2013. 28
[2]Nagpal M, Nagpal K, Nagpal P N. Postcataract cystoid macular edema[J]. Ophthalmol Clin North Am, 2001, 14(4): 651-659, ix.
[3]Sheu S J, Wu T T, Horng Y H. Efficacy and Safety of Dexamethasone Intravitreal Implant for Treatment of Refractory Macular Edema Secondary to Retinal Vein Occlusion in Taiwan[J]. J Ocul Pharmacol Ther, 2015, 31(8): 461-467. DOI: 10. 1089/jop. 2014. 0119
[4]李元彬, 高波, 陈宁, 等. 玻璃体腔注射曲安奈德治疗白内障术后黄斑囊样水肿疗效观察[J]. 国际眼科杂志, 2008, 8(1): 153-155.
[5]蔡克波. Avastin治疗视网膜中央静脉阻塞后顽固性黄斑水肿的疗效[J]. 实用医学杂志, 2009, 25(24): 4202-4203.
[6]余秋蓉, 朱思泉. 白内障术后黄斑囊样水肿的研究进展[J]. 国际眼科杂志, 2005, 5(5): 983-986.
[7]Gotebiewska J, Kcik D, Turczyńska M, et al. Evaluation of macular thickness after uneventful phacoemulsification in selected patient populations using optical coherence tomography[J]. Klinika Oczna, 2014, 116(4): 242-247.
[8]许超, 王艳玲. 白内障超声乳化术后黄斑囊样水肿的发病机制及致病因子[J]. 临床和实验医学杂志, 2009(2): 129-130.
[9]Bringmann A, Reichenbach A, Wiedemann P. Pathomechanisms of cystoid macular edema[J]. Ophthalmic Research, 2004, 36(5): 241-249.
[10]Gulkilik G, Kocabora S, Taskapili M, et al. Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity[J]. Can J Ophthalmol, 2006, 41(6): 699-703.
[11]Pikkel J, Chassid O, Busool Y, et al. Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome[J]. J Ophthalmol, 2013(3): 215-226. DOI: 10. 1155/2013/974670
[12]Studnicka J. Aflibercept in the Diabetic Macular Edema Treatment[J]. Cesk Slov Oftalmol, 2015, 71(5): 243-246.
[13]刘珊, 张晓峰. 抗VEGF药物治疗黄斑水肿的研究进展[J]. 临床眼科杂志, 2012, 20(6): 567-571.

相似文献/References:

[1]劣虹璇,李世迎,刘勇,等.巩膜后注射曲安奈德治疗视网膜色素变性黄斑水肿的短期疗效分析[J].第三军医大学学报,2015,37(08 ):804.
 Lie Hongxuan,Li Shiying,Liu Yong,et al.Efficacy of post-sclera injection of triamcinolone acetonide on patients with retinitis pigmentosa accompanied by macula edema[J].J Third Mil Med Univ,2015,37(20):804.

更新日期/Last Update: 2016-10-24